Updates are available Correction dated 2023-05-16
Click to view Correction: https://doi.org/10.1007/s10072-023-06856-z
-
Authors
Zhou, Zhou
Lu, Wei
Zhang, Cheng
Xiang, Lan
Xiang, Liang
Chen, Chen
Wang, BiJun
Guo, LeHeng
Shan, YaJie
Li, XueMei
Zhao, Zheng
Zou, JianJun http://orcid.org/0000-0003-0886-3153
Dai, XiaoMing
Zhao, ZhiHong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82173899)
Jiangsu Pharmaceutical Association (H202108, Q202202, A2021024)
Natural Science Foundation of Hunan Province (2021JJ70021)
Hunan innovation guidance grant of clinical medical technology (2020SK50920)
- License Information
-
More Information
Article History
Received: 21 January 2023
Accepted: 22 March 2023
First Online: 5 April 2023
Change Date: 16 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10072-023-06856-z
Declarations
:
: The studies involving human participants were reviewed and approved by the Human Research Ethics committee of Hunan Provincial People’s Hospital (article number: [2015]-10).
: The ethics committee waived the requirement of written informed consent for participation.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Free to read: This content has been made available to all.
